T Cell Maturation,Activation and Differentiation



Similar documents
B Cell Generation, Activation & Differentiation. B cell maturation

B cell activation and Humoral Immunity

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

Cytotoxic T Lymphocytes (CTLs) and NK Cells. Effector T cells. After activation, naïve T cells differentiate into effector and memory T cells

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES

Antibody Function & Structure

Activation and effector functions of HMI

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS.

Name (print) Name (signature) Period. (Total 30 points)

B Cells and Antibodies

Problem Set 6 KEY

2) Macrophages function to engulf and present antigen to other immune cells.

Chapter 43: The Immune System

Microbiology AN INTRODUCTION EIGHTH EDITION

Module 2: Antibodies and Antigens

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

Chapter 18: Applications of Immunology

The Immune System: A Tutorial

Autoimmunity and immunemediated. FOCiS. Lecture outline

One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types:

Dendritic Cells: A Basic Review *last updated May 2003

B Lymphocyte (B cell)

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

Applications of Ab Molecules. Chapter 4 Monoclonal Ab (p.99) Chapter 5 Ab genes and Ab Engineering (p.128)

Actions of Hormones on Target Cells Page 1. Actions of Hormones on Target Cells Page 2. Goals/ What You Need to Know Goals What You Need to Know

Making the switch to a safer CAR-T cell therapy

Chapter 5: Organization and Expression of Immunoglobulin Genes

The Body s Defenses CHAPTER 24

MHC (MAJOR HISTOCOMPATIBILITY COMPLEX)

Recognition of T cell epitopes (Abbas Chapter 6)

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

Final Review. Aptamers. Making Aptamers: SELEX 6/3/2011. sirna and mirna. Central Dogma. RNAi: A translation regulation mechanism.

MONOCLONAL ANTIBODY PRODUCTION

Hormones & Chemical Signaling

Chapter-21b: Hormones and Receptors

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

TABLE OF CONTENT. Page ACKNOWLEDGEMENTS. iii ENGLISH ABSTRACT THAI ABSTRACT. vii LIST OF TABLES LIST OF FIGURES. xvi ABBREVIATIONS.

3) There are different types of extracellular signaling molecules. 4) most signaling molecules are secreted by exocytosis

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

ELISA BIO 110 Lab 1. Immunity and Disease

Guidance for Industry

Antibody Structure, and the Generation of B-cell Diversity CHAPTER 4 04/05/15. Different Immunoglobulins

Custom Antibody Services

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

The Most Common Autoimmune Disease: Rheumatoid Arthritis. Bonita S. Libman, M.D.

The Costimulatory Molecule CD27 Maintains Clonally

Mechanisms of Hormonal Action Bryant Miles

Basics of Immunology

NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds

Why use passive immunity?

Immunology Ambassador Guide (updated 2014)

From cells to therapeuticsvivalis. Humalex Fully human antibody discovery platform An integrated therapeutic development offering

Custom Antibodies & Recombinant Proteins

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

KMS-Specialist & Customized Biosimilar Service

How To Make A Hybridoma

Immunosuppression for Solid Organ and Bone Marrow Transplantation Thomas R Spitzer, MD

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

Some terms: An antigen is a molecule or pathogen capable of eliciting an immune response

Antigens & Antibodies II. Polyclonal antibodies vs Monoclonal antibodies

Mouse IFN-gamma ELISpot Kit

The Immune System. 2 Types of Defense Mechanisms. Lines of Defense. Line of Defense. Lines of Defense

Immunity. Humans have three types of immunity innate, adaptive, and passive: Innate Immunity

The immune response Antibodies Antigens Epitopes (antigenic determinants) the part of a protein antigen recognized by an antibody Haptens small

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

CHAPTER 9 IMMUNOGLOBULIN BIOSYNTHESIS

Immunology. B lymphocytes & Antibodies , Ruhr-Universität Bochum Marcus Peters, marcus.peters@rub.de

Types, production of antibodies and Antibody/antigen interaction

Human CD4+T Cell Care Manual

Understanding the immune response to bacterial infections

Are CAR T-Cells the Solution for Chemotherapy Refractory Diffuse Large B-Cell Lymphoma? Umar Farooq, MD University of Iowa Hospitals and Clinics

Modelling and analysis of T-cell epitope screening data.

Diabetes and Insulin Signaling

OKT3. ~ The first mouse monoclonal antibody. used in clinical practice in the field of transplantation ~

Malignant Lymphomas and Plasma Cell Myeloma

CUSTOM ANTIBODIES. Fully customised services: rat and murine monoclonals, rat and rabbit polyclonals, antibody characterisation, antigen preparation

Chapter 3. Immunity and how vaccines work

Advanced BioDesign Outlines Solutions. Antibody Overview. by Advanced BioDesign. Project Start. Immunogenicity. Selecting Your Antigen

BioMmune Technologies Inc. Corporate Presentation 2015

Potency Assays for an Autologous Active Immunotherapy (Sipuleucel-T) Pocheng Liu, Ph.D. Senior Scientist of Product Development Dendreon Corporation

Chapter 3.2» Custom Monoclonal

International Beryllium Conference, Montreal, Canada March 10, 2005

Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes

Multiple Myeloma and Colorectal Cancer

Immuno-Oncology Therapies to Treat Lung Cancer

Immunosuppressive drugs

Figure 14.2 Overview of Innate and Adaptive Immunity

The Immune System. How your immune system works. Organs of the Immune System

MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères Evry Cedex. is involved at each stage of your project

Transcription:

T Cell Maturation,Activation and Differentiation Positive Selection- In thymus, permits survival of only those T cells whose TCRs recognize self- MHC molecules (self-mhc restriction) Negative Selection- eliminates T cells that react too strongly with self-mhc or with self-mhc plus self-peptides. When arrive at thymus progenitor T cells do not express surface molecules (I.e., no CD4, 8 or TCR). Not yet re-arranged TCR genes

T progenitor cells enter cortex spend 3 weeks in development with changes in surface markers double negative at first (no CD4 or CD8) c-kit (receptor for stem-cell growth factor), CD44 (adhesion molecule), and CD25 (the alpha chain of IL-2 receptor) Cells continue to proliferate and DO NOT express TCR. Cell stops proliferating, stops expressing c-kit, reduce CD44 and begin to rearrange TCR genes rearrange Beta TCR chain and this associates with a pre-t alpha chain (pre-t cell receptor [pre-tcr])- this recognizes some intrathymic ligand and transmits a signal through CD3 that activates Lck, a protein tyrosine kinase

The activation of TK selects cells expressing beta chain for further expansion and maturation Suppresses further rearrangement of beta chain TCR gene Enhances rearrangement of alpha chain TCR Induces development to double positive CD4 + 8 + These cells proliferate, but alpha cannot rearrange because RAG-2 is degraded quickly in cells that are proliferating. This creates greater diversity by generating a clone of cells with a single TCR beta chain rearrangement which can then associate with many different alpha chains

As TCR alpha is being made the T cell begins undergoing positive and negative selection Double positive (DP) cells express the alpha and beta TCR-CD3 complex and develop into either single-positive CD4 + or CD8 + cells.

T H Cell Activation Initiated by interaction of TCR-CD3 complex with processed antigenic peptide bound to class II on APCs proliferates into memory and effector cells, and many genes activated (see table 10-3). Immediate genes- Fos, jun, NF-AT, myc, NFkB early genes-- IFN-gamma, IL-2, IL-2R, IL-3, TGF,.. Late genes- HLA-DR, VLA-4 and other VLAs,. (adhesion molecules) These events brought about by signal transduction: receptor --> 2 nd messengers (DAG, PI 3, camp, CA ++ )-- > protein kinases (TK, PKC, calmodulin.)---> ---> gene activation through NF (nuclear binding factors)

Cross-linking of TCR necessary & occurs by linking with MHC-peptide complexes (can activate using F(ab) 2 or antibody that cross links CD3. Activation of ITAM (immunoreceptor tyrosine-based activation motif) on cytoplasmic tail of CD3 molecules Phosphorylation of tyrosines in ITAMs by Fyn and Lck is early consequence of cross-linking TCR. Phosphorylation of inhibitory site (turns off activity) and active site. To be active not only must be phosphorylated at active site but inhibitory P must be removed by phosphatase (CD45- transmembrane phosphatase)

Once released the active Lck and Fyn phosphorylate tyrosine residues in ITAMs of CD3 complex phosphorylation of. Chain creates a docking site for ZAP-70 (zeta-associated protein) and when this binds to ITAM the TK activity of ZAP- 70 is activated by Lck and Fyn phosphorylation. Activation of ZAP-70 leads to activation of many pathways (I.e., PKC (activates and causes release of NF-6B) [IP 3 and DAG], calcineurin (calmodulin-dependent phosphatase) which dephosphorylates the inactive cytosolic form of the nuclear factor NF-AT. Both NF factors activate genes (I.e., IL-2 and IL-2R)

T cells require two signals for activation Signal 1: interaction of an antigenic peptide with the TCR-CD3 complex Signal 2: Antigen-nonspecific co-stimulatory signal provided by interactions between CD28 on the T cell and B7 proteins on APC. Ligands for B7 are CD28 and CTLA-4 (CD 152) [these act antagonistically with each other] CD28 expressed on both resting and activated T cells but CTLA-4 found only on activated cells (24 h after stimulation). CD27 & B7 stimulates (augments) IL-2 production and proliferation. Signal 1 without signal 2 produces ANERGY

Superantigens- Bind simultaneously to the V $ domain of a T-cell receptor and to the " chain of a class II MHC molecule. (outside of TCR cleft) Exogenous superantigens-- soluble proteins secreted by bacteria (I.e., staphylcoccal enterotoxins, toxic shock syndrome toxin, exfoliative-dermatitis toxin, mycoplasma-arthritidis supernatant and streptococcal pyrogenic exotoxins. Endogenous superantigens-- cell-membrane protein encoded by certain viruses that infect mammalian cells. These viral proteins are called minor lymphocyte stimulating (Mls) determinants. Since superantigens bind outside of the TCR antigen-binding cleft any T cell expressing a particular V $ sequence will be activated (polyclonal response).

T-cell differentiation- CD4+ and CD8+ cells leave thymus and enter circulation as resting cells (naïve cells). These continually recirculate between blood and lymph system. During recirculation the naïve T cells reside in the LN and Spleen, but if it does not encounter antigen it exits and rejoins blood. Circulates from blood to LN and back to blood every 12-24 hours. 1 in 10 5 naïve T cells specific for any given antigen, and recirculation increases chances that it will encounter antigen Thought to survive only 5-7 weeks if it does not encounter Ag. Some cells may life a lot longer Effector & Memory T cells- After Ag encounter, naïve T cell enlarges into blast cell (~48 hours) and proliferates. At same time stabilization of IL-2 mrna increases production by 100X, and secretion causes it to bind to IL-2R (divides 2-3 times for 4-5 day period). Produces large CLONE which differentiate into memory and effector cells.

Effector T cells carry out specialized functions (cytokine production and B-cell help). These come from both naïve and memory cells and effector cells live short llife span (few days to a few weeks) 2 populations of effector cells T H 1 subset- secrete IL-s, IFN-(, TNF-$. This subset is responsible for the classic cell-mediated functions (delayed type hypersensitivity and activation of T C. T H 2 subset- secretes IL-4, IL-5, IL-6, and IL-10. Functions more effectively as a helper for B-cell activation and class switch reactions of Ig.

Hybridoma Technology Production of monoclonal antibodies Antibodies that are from a single B cell (clone) How to isolate and make Fusion of B cell that produces antibody with a tumor cell that is immortal Selection in HAT media Unfused B cells will die because of limited life-span and tumor cells will die because they do not have the ability (due to mutation) to make their own purine bases (HAT is selective) Select for cell that is producing antibody you want